Karyopharm Therapeutics Inc
(NAS:KPTI)
$
0.6763
-0.0238 (-3.4%)
Market Cap: 85.34 Mil
Enterprise Value: 149.08 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 68/100 Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Mar 15, 2023 / 08:35PM GMT
Release Date Price:
$3.48
(-1.14%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst
Thank you so much. Good afternoon. Welcome to Barclays Healthcare Conference in Miami. And my name is Peter Lawson. I'm one of the SMID Cap Biotech Analyst at Barclays, focused around oncology. And do e-mail me or send us Bloomberg's if you need any questions addressed for this fireside chat.
Really delighted to have with us management team from Karyopharm. And I do this slightly differently versus some of the others. I think management changed, I mean, I guess it's been a couple of years now?
Richard A. Paulson
Karyopharm Therapeutics Inc. - President, CEO & Director
Almost 2 years now, Peter. Yes.
Questions & Answers
Peter Richard Lawson;Richard A. Paulson<
Barclays Bank PLC, Research Division - Research Analyst
It would be great to get kind of the driving force behind the change and kind of where you came from and the experience you brought that kind of helped transform in this direction?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot